Mutations of the BRAF gene can cause BRAF phosphorylation and activation of MEK proteins (MEK 1 and MEK 2), thereby causing sustained activation of the downstream MEK-ERK signaling pathway, exacerbating melanoma growth, proliferation, invasion, and metastasis [108,109]. The gene discussed is BRAF; the disease is melanoma.